EMEA-000977-PIP01-10 - paediatric investigation plan

house dust mites allergen extract from Dermatophagoides pteronyssinus and Dermatophagoides farinae (50/50)

Key facts

• Active substance:
  house dust mites allergen extract from Dermatophagoides pteronyssinus and Dermatophagoides farinae (50/50)
• Therapeutic area:
  Pneumology-allergology
• Decision number:
  P/34/2011
• PIP number:
  EMEA-000977-PIP01-10
• Pharmaceutical form(s):
  Oral solution
• Condition(s) / indication(s):
  Treatment of allergic rhinitis / rhino-conjunctivitis
• Route(s) of administration:
  Sublingual use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  28/01/2011
• Compliance check done:
  No

Decision

P/34/2011: EMA decision of 28 January 2011 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for house dust mites allergen extract from Dermatophagoide...

Adopted Reference Number: EMA/58433/2011